Han H, Yang Y, Jiao Y, Qi H, Han Z, Wang L, et al. Leverage of nuclease-deficient CasX for preventing pathological angiogenesis. Mol Ther Nucleic Acids. 2023;33:738-748 pubmed publisher

Boender A, Boon M, Albers H, Eck S, Fricker B, Kelly A, et al. An AAV-CRISPR/Cas9 strategy for gene editing across divergent rodent species: Targeting neural oxytocin receptors as a proof of concept. Sci Adv. 2023;9:eadf4950 pubmed publisher

Wu W, Yang Y, Yao F, Dong L, Xia X, Zhang S, et al. AAV-mediated in vivo genome editing in vascular endothelial cells. Methods. 2020;: pubmed publisher

Moghadam F, LeGraw R, Velazquez J, Yeo N, Xu C, Park J, et al. Synthetic immunomodulation with a CRISPR super-repressor in vivo. Nat Cell Biol. 2020;22:1143-1154 pubmed publisher

Duan Y, Ma G, Huang X, D Amore P, Zhang F, Lei H. The Clustered, Regularly Interspaced, Short Palindromic Repeats-associated Endonuclease 9 (CRISPR/Cas9)-created MDM2 T309G Mutation Enhances Vitreous-induced Expression of MDM2 and Proliferation and Survival of Cells. J Biol Chem. 2016;291:16339-47 pubmed publisher